Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Screeners that run automatically... and then email you the results! FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Natera Inc (NTRA)

Natera Inc (NTRA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,272,895
  • Shares Outstanding, K 96,957
  • Annual Sales, $ 625,490 K
  • Annual Income, $ -471,720 K
  • 60-Month Beta 1.34
  • Price/Sales 6.79
  • Price/Cash Flow N/A
  • Price/Book 9.49
Trade NTRA with:

Options Overview Details

View History
  • Implied Volatility 77.62% ( -6.45%)
  • Historical Volatility 58.46%
  • IV Percentile 47%
  • IV Rank 37.04%
  • IV High 137.66% on 03/09/22
  • IV Low 42.29% on 11/05/21
  • Put/Call Vol Ratio 1.06
  • Today's Volume 111
  • Volume Avg (30-Day) 398
  • Put/Call OI Ratio 1.00
  • Today's Open Interest 10,107
  • Open Int (30-Day) 8,316

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/22
See More
  • Average Estimate -1.42
  • Number of Estimates 5
  • High Estimate -1.34
  • Low Estimate -1.47
  • Prior Year -1.63
  • Growth Rate Est. (year over year) +12.88%

Price Performance

See More
Period Period Low Period High Performance
1-Month
42.52 +12.68%
on 09/26/22
53.58 -10.58%
on 09/12/22
+0.26 (+0.55%)
since 09/02/22
3-Month
35.57 +34.69%
on 07/05/22
57.88 -17.23%
on 08/11/22
+10.98 (+29.73%)
since 07/01/22
52-Week
26.10 +83.56%
on 03/09/22
121.05 -60.42%
on 11/08/21
-61.55 (-56.23%)
since 10/04/21

Most Recent Stories

More News
Trifecta Study Demonstrates Prospera™ Kidney dd-cfDNA Test Outperforms DSA in Predicting Antibody Mediated Rejection

/PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA (cfDNA) testing, today announced the publication of the latest data from the...

NTRA : 47.91 (+8.71%)
Is Illumina Still the Gamechanger in Genomics Sequencing?

Genome sequencing solutions company Illumina (NASDAQ: ILMN) stock has fallen under its pandemic lows. A surprise earnings miss, and lowered guidance has caused

ILMN : 205.06 (+9.52%)
NTRA : 47.91 (+8.71%)
EXAS : 36.16 (+8.59%)
MYGN : 20.61 (+5.26%)
AZN : 57.04 (+2.68%)
Natera Presents New Colorectal and Breast Cancer Data at ESMO 2022, Highlighting Signatera's Ability to Inform Treatment Decisions in the Adjuvant and Neoadjuvant Settings

/PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced new data on its personalized and tumor-informed...

NTRA : 47.91 (+8.71%)
Natera to Participate in Upcoming Investor Conferences

/PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced that Steve Chapman, chief executive officer, and Mike...

NTRA : 47.91 (+8.71%)
Natera Earns Great Place to Work Certification™ for Second Consecutive Year

/PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, is proud to be certified by Great Place to Work® for the second...

NTRA : 47.91 (+8.71%)
Natera Announces Enrollment Completion for RenaCARE Study

/PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced full enrollment for the RenaCARE (Renasight Clinical...

NTRA : 47.91 (+8.71%)
Natera Announces Q-Sub Filing with FDA for its Panorama® NIPT

/PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, announced earlier today at the Canaccord Genuity 42nd Annual Growth...

NTRA : 47.91 (+8.71%)
Natera (NTRA) Reports Q2 Loss, Tops Revenue Estimates

Natera (NTRA) delivered earnings and revenue surprises of -2.04% and 2.11%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

NTRA : 47.91 (+8.71%)
GDRX : 5.32 (+8.13%)
Wall Street Analysts Predict a 47% Upside in Natera (NTRA): Here's What You Should Know

The consensus price target hints at a 47.5% upside potential for Natera (NTRA). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions...

NTRA : 47.91 (+8.71%)
Natera Announces Second Quarter 2022 Earnings Conference Call

/PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced that it will release results for its second quarter...

NTRA : 47.91 (+8.71%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California.

See More

Key Turning Points

3rd Resistance Point 51.71
2nd Resistance Point 49.98
1st Resistance Point 48.95
Last Price 47.91
1st Support Level 46.19
2nd Support Level 44.46
3rd Support Level 43.43

See More

52-Week High 121.05
Fibonacci 61.8% 84.78
Fibonacci 50% 73.58
Fibonacci 38.2% 62.37
Last Price 47.91
52-Week Low 26.10

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar